Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-23

Clinical Trial Update: Administration of Tadalafil in Patients With Benign Prostatic Hyperplasia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating tadalafil in patients with benign prostatic hyperplasia has completed. The study assessed tadalafil for BPH with lower urina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TADALAFIL (TADALAFIL)

Snippet

Sponsor: Al-Azhar University | Conditions: BPH With Other Lower Urinary Tract Symptoms | Phase 3 | Status: COMPLETED